Kong Y, et al. PHF12 regulates HDAC1 to promote tumorigenesis via EGFR/AKT signaling pathway in non-small cell lung cancer. J Transl Med,2024;22(1):689. Ji X, et al. Efficacy and safety of immune checkpoint inhibitors for advanced non-small cell lung cancer with leptomeningeal metastases harboring targetable mutations. Transl Lung Cancer Res,2024;13(7):1695-1707 Lin H, et al. Efficacy and Safety of Apatinib in Patients with Recurrent Glioblastoma. Drugs R D,2023;23(3):239-244. Kong Y, et al. MIB2 promotes the progression of non-small cell lung cancer by regulating cell cycle control pathways. Genes Genomics,2023;45(9):1143-1152. Wang Y, et al. Clinical Outcomes of Patients with Epidermal Growth Factor Receptor-Mutated Non-Small-Cell Lung Cancer with Leptomeningeal Metastasis in the Modern Target Therapy Era. World Neurosurg,2023;170:e500-e509 Su Y, et al. RIT1 regulates mitosis and promotes proliferation by interacting with SMC3 and PDS5 in hepatocellular carcinoma. J Exp Clin Cancer Res,2023;42(1):326